Nitroglycerin, also known as glyceryl trinitrate (GTN), is a vasodilator used for heart failure, high blood pressure, anal fissures, painful periods, treating the pain from esophageal spasm, and to treat and prevent chest pain caused by decreased blood flow to the heart (angina) or due to the recreational use of cocaine.[1][2][3][4] This includes chest pain from a heart attack. It is taken by mouth, under the tongue, applied to the skin by cream or a patch, as a spray, or by injection into a vein.[5][6]
Common side effects include headache and low blood pressure.[5] The low blood pressure can be severe.[5] It is unclear if use in pregnancy is safe for the fetus.[5] It should not be used together with medications within the PDE5 inhibitor family such as sildenafil due to the risk of low blood pressure.[5] Nitroglycerin is in the nitrate family of medications.[5] While it is not entirely clear how it works, it is believed to function by dilating blood vessels.[5]
Nitroglycerin was written about as early as 1846 and came into medical use in 1878.[7][8] The drug nitroglycerin is a dilute form of the same chemical used as the explosive, nitroglycerin.[8] Dilution makes it non-explosive.[8] In 2023, it was the 207th most commonly prescribed medication in the United States, with more than 2million prescriptions.[9][10]
Medical uses
Nitroglycerin is used for the treatment of angina, acute myocardial infarction, severe hypertension, and acute coronary artery spasms.[5][11] It may be administered intravenously, as a sublingual spray/tablet, or as a patch applied to the skin.
Angina
Nitroglycerin is useful in decreasing angina attacks, perhaps more so than reversing angina once started, by supplementing blood concentrations of NO, also called endothelium-derived relaxing factor, before the structure of NO as the responsible agent was known. This led to the development of transdermal patches of nitroglycerin, providing 24-hour release.[12] However, the effectiveness of nitroglycerin is limited by development of tolerance/tachyphylaxis within 2–3 weeks of sustained use. Continuous administration and absorption (such as provided by daily pills and especially skin patches) accelerate onset of tolerance and limit the usefulness of the agent.
Adverse events
Nitroglycerin can cause severe hypotension, reflex tachycardia, and severe headaches that necessitate analgesic intervention for pain relief, the painful nature of which can have a marked negative effect on patient compliance.[35]
Nitroglycerin also can cause severe hypotension, circulatory collapse, and death if used together with vasodilator drugs that are used for erectile dysfunction, such as sildenafil, tadalafil, and vardenafil.[36]
Nitroglycerin transdermal patches should be removed before defibrillation due to the risk of explosion or burns, but investigations have concluded that nitroglycerin patch explosions during defibrillation were due to the breakdown voltage of the metal mesh in some patches.[37][38]
Mechanism of action
Nitroglycerin is a prodrug which must be denitrated, with the nitrite anion or a related species further reduced to produce the active metabolite nitric oxide (NO). Organic nitrates that undergo these two steps within the body are called nitrovasodilators, and the denitration and reduction occur via a variety of mechanisms. The mechanism by which such nitrates produce NO is widely disputed. It has been postulated that organic nitrates produce NO by reacting with sulfhydryl groups, while others believe that enzymes such as glutathione S-transferases, cytochrome P450 (CYP), and xanthine oxidoreductase are the primary source of nitroglycerin bioactivation.[39]
The NO produced by this process is a potent activator of guanylyl cyclase (GC) by heme-dependent mechanisms; this activation results in formation of cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP). Among other roles, cGMP serves as a substrate for a cGMP-dependent protein kinase that activates myosin light chain phosphatase. Thus, production of NO from exogenous sources such as nitroglycerin increases the level of cGMP within the cell, and stimulates dephosphorylation of myosin, which initiates relaxation of smooth muscle cells in blood vessels.[40]
History
It was known almost from the time of the first synthesis of nitroglycerin by Ascanio Sobrero in 1846 that handling and tasting of nitroglycerin could cause sudden intense headaches,[41][42] which suggested a vasodilation effect.[43] Constantine Hering developed a form of nitroglycerin in 1847 and advocated for its dosing as a treatment of a number of diseases; however, its use as a specific treatment for blood pressure and chest pain was not among these. This is primarily due to his deep rooted focus in homeopathy.[44][45]
Following Thomas Brunton's discovery that amyl nitrite could be used to treat chest pain, William Murrell experimented with the use of nitroglycerin to alleviate angina and reduce
Society and culture
Brand names
In the United States, the tablet form of nitroglycerin is marketed (brand name Nitrostat)[50] by Viatris after Upjohn was spun off from Pfizer.[51][52][53]
Nitroglycerin used for treatment of angina has multiple brand names depending on the mode of administration, such as Minitran, Nitro-Dur, Nitrolingual, Nitromist, and Nitro-Bid[54]
Further reading
References
- 0.4% nitroglycerin ointment : in the treatment of chronic anal fissure pain Drugs, 2006^
- Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm The New England Journal of Medicine, Massachusetts Medical Society, July 1973^
- Nitroglycerin as a uterine relaxant: a systematic review Journal of Obstetrics and Gynaecology Canada, May 2002^